Anti-CTLA-4 therapy broadens the melanoma-reactive CD8(+) T cell response

Author(s):
Kvistborg, P.; Philips, D.; Kelderman, S.; Hageman, L.; Ottensmeier, C.; Joseph-Pietras, D.; Welters, M.J.P.; Burg, S. van der; Kapiteijn, E.; Michielin, O.; Romano, E.; Linnemann, C.; Speiser, D.; Blank, C.; Haanen, J.B.; Schumacher, T.N.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-09-17
Language
English
Is part of
Science Translational Medicine (2014), No. 254
hdl
1887/104586
doi
10.1126/scitranslmed.3008918